Pulmonary Embolism Drug Market
1 Study Coverage
1.1 Pulmonary Embolism Drug Product Introduction
1.2 Market by Type
1.2.1 Global Pulmonary Embolism Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DS-9231
1.2.3 DS-1040
1.2.4 TRX-1
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pulmonary Embolism Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pulmonary Embolism Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Pulmonary Embolism Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Pulmonary Embolism Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pulmonary Embolism Drug Sales by Region
2.4.1 Global Pulmonary Embolism Drug Sales by Region (2017-2022)
2.4.2 Global Sales Pulmonary Embolism Drug by Region (2023-2028)
2.5 Global Pulmonary Embolism Drug Revenue by Region
2.5.1 Global Pulmonary Embolism Drug Revenue by Region (2017-2022)
2.5.2 Global Pulmonary Embolism Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pulmonary Embolism Drug Sales by Manufacturers
3.1.1 Global Top Pulmonary Embolism Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Pulmonary Embolism Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Embolism Drug in 2021
3.2 Global Pulmonary Embolism Drug Revenue by Manufacturers
3.2.1 Global Pulmonary Embolism Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Pulmonary Embolism Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Embolism Drug Revenue in 2021
3.3 Global Pulmonary Embolism Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pulmonary Embolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pulmonary Embolism Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pulmonary Embolism Drug Sales by Type
4.1.1 Global Pulmonary Embolism Drug Historical Sales by Type (2017-2022)
4.1.2 Global Pulmonary Embolism Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
4.2 Global Pulmonary Embolism Drug Revenue by Type
4.2.1 Global Pulmonary Embolism Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Pulmonary Embolism Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
4.3 Global Pulmonary Embolism Drug Price by Type
4.3.1 Global Pulmonary Embolism Drug Price by Type (2017-2022)
4.3.2 Global Pulmonary Embolism Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pulmonary Embolism Drug Sales by Application
5.1.1 Global Pulmonary Embolism Drug Historical Sales by Application (2017-2022)
5.1.2 Global Pulmonary Embolism Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
5.2 Global Pulmonary Embolism Drug Revenue by Application
5.2.1 Global Pulmonary Embolism Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Pulmonary Embolism Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
5.3 Global Pulmonary Embolism Drug Price by Application
5.3.1 Global Pulmonary Embolism Drug Price by Application (2017-2022)
5.3.2 Global Pulmonary Embolism Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pulmonary Embolism Drug Market Size by Type
6.1.1 North America Pulmonary Embolism Drug Sales by Type (2017-2028)
6.1.2 North America Pulmonary Embolism Drug Revenue by Type (2017-2028)
6.2 North America Pulmonary Embolism Drug Market Size by Application
6.2.1 North America Pulmonary Embolism Drug Sales by Application (2017-2028)
6.2.2 North America Pulmonary Embolism Drug Revenue by Application (2017-2028)
6.3 North America Pulmonary Embolism Drug Market Size by Country
6.3.1 North America Pulmonary Embolism Drug Sales by Country (2017-2028)
6.3.2 North America Pulmonary Embolism Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pulmonary Embolism Drug Market Size by Type
7.1.1 Europe Pulmonary Embolism Drug Sales by Type (2017-2028)
7.1.2 Europe Pulmonary Embolism Drug Revenue by Type (2017-2028)
7.2 Europe Pulmonary Embolism Drug Market Size by Application
7.2.1 Europe Pulmonary Embolism Drug Sales by Application (2017-2028)
7.2.2 Europe Pulmonary Embolism Drug Revenue by Application (2017-2028)
7.3 Europe Pulmonary Embolism Drug Market Size by Country
7.3.1 Europe Pulmonary Embolism Drug Sales by Country (2017-2028)
7.3.2 Europe Pulmonary Embolism Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pulmonary Embolism Drug Market Size by Type
8.1.1 Asia Pacific Pulmonary Embolism Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Pulmonary Embolism Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Pulmonary Embolism Drug Market Size by Application
8.2.1 Asia Pacific Pulmonary Embolism Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Pulmonary Embolism Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Pulmonary Embolism Drug Market Size by Region
8.3.1 Asia Pacific Pulmonary Embolism Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Pulmonary Embolism Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pulmonary Embolism Drug Market Size by Type
9.1.1 Latin America Pulmonary Embolism Drug Sales by Type (2017-2028)
9.1.2 Latin America Pulmonary Embolism Drug Revenue by Type (2017-2028)
9.2 Latin America Pulmonary Embolism Drug Market Size by Application
9.2.1 Latin America Pulmonary Embolism Drug Sales by Application (2017-2028)
9.2.2 Latin America Pulmonary Embolism Drug Revenue by Application (2017-2028)
9.3 Latin America Pulmonary Embolism Drug Market Size by Country
9.3.1 Latin America Pulmonary Embolism Drug Sales by Country (2017-2028)
9.3.2 Latin America Pulmonary Embolism Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pulmonary Embolism Drug Market Size by Type
10.1.1 Middle East and Africa Pulmonary Embolism Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pulmonary Embolism Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Pulmonary Embolism Drug Market Size by Application
10.2.1 Middle East and Africa Pulmonary Embolism Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pulmonary Embolism Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Pulmonary Embolism Drug Market Size by Country
10.3.1 Middle East and Africa Pulmonary Embolism Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pulmonary Embolism Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Accu-Break Pharmaceuticals, Inc.
11.1.1 Accu-Break Pharmaceuticals, Inc. Corporation Information
11.1.2 Accu-Break Pharmaceuticals, Inc. Overview
11.1.3 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Accu-Break Pharmaceuticals, Inc. Recent Developments
11.2 Dong-A Socio Holdings Co. Ltd.
11.2.1 Dong-A Socio Holdings Co. Ltd. Corporation Information
11.2.2 Dong-A Socio Holdings Co. Ltd. Overview
11.2.3 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dong-A Socio Holdings Co. Ltd. Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd. Overview
11.3.3 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Genentech, Inc.
11.4.1 Genentech, Inc. Corporation Information
11.4.2 Genentech, Inc. Overview
11.4.3 Genentech, Inc. Pulmonary Embolism Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Genentech, Inc. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Genentech, Inc. Recent Developments
11.5 Verseon Corp
11.5.1 Verseon Corp Corporation Information
11.5.2 Verseon Corp Overview
11.5.3 Verseon Corp Pulmonary Embolism Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Verseon Corp Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Verseon Corp Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pulmonary Embolism Drug Industry Chain Analysis
12.2 Pulmonary Embolism Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pulmonary Embolism Drug Production Mode & Process
12.4 Pulmonary Embolism Drug Sales and Marketing
12.4.1 Pulmonary Embolism Drug Sales Channels
12.4.2 Pulmonary Embolism Drug Distributors
12.5 Pulmonary Embolism Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pulmonary Embolism Drug Industry Trends
13.2 Pulmonary Embolism Drug Market Drivers
13.3 Pulmonary Embolism Drug Market Challenges
13.4 Pulmonary Embolism Drug Market Restraints
14 Key Findings in The Global Pulmonary Embolism Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pulmonary Embolism Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of DS-9231
Table 3. Major Manufacturers of DS-1040
Table 4. Major Manufacturers of TRX-1
Table 5. Major Manufacturers of Others
Table 6. Global Pulmonary Embolism Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Pulmonary Embolism Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Pulmonary Embolism Drug Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Pulmonary Embolism Drug Sales Market Share by Region (2017-2022)
Table 10. Global Pulmonary Embolism Drug Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Pulmonary Embolism Drug Sales Market Share by Region (2023-2028)
Table 12. Global Pulmonary Embolism Drug Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Pulmonary Embolism Drug Revenue Market Share by Region (2017-2022)
Table 14. Global Pulmonary Embolism Drug Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Pulmonary Embolism Drug Revenue Market Share by Region (2023-2028)
Table 16. Global Pulmonary Embolism Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Pulmonary Embolism Drug Sales Share by Manufacturers (2017-2022)
Table 18. Global Pulmonary Embolism Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Pulmonary Embolism Drug Revenue Share by Manufacturers (2017-2022)
Table 20. Pulmonary Embolism Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Pulmonary Embolism Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pulmonary Embolism Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Embolism Drug as of 2021)
Table 23. Pulmonary Embolism Drug Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pulmonary Embolism Drug Product Offered
Table 25. Date of Manufacturers Enter into Pulmonary Embolism Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pulmonary Embolism Drug Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Pulmonary Embolism Drug Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Pulmonary Embolism Drug Sales Share by Type (2017-2022)
Table 30. Global Pulmonary Embolism Drug Sales Share by Type (2023-2028)
Table 31. Global Pulmonary Embolism Drug Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Pulmonary Embolism Drug Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Pulmonary Embolism Drug Revenue Share by Type (2017-2022)
Table 34. Global Pulmonary Embolism Drug Revenue Share by Type (2023-2028)
Table 35. Pulmonary Embolism Drug Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Pulmonary Embolism Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Pulmonary Embolism Drug Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Pulmonary Embolism Drug Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Pulmonary Embolism Drug Sales Share by Application (2017-2022)
Table 40. Global Pulmonary Embolism Drug Sales Share by Application (2023-2028)
Table 41. Global Pulmonary Embolism Drug Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Pulmonary Embolism Drug Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Pulmonary Embolism Drug Revenue Share by Application (2017-2022)
Table 44. Global Pulmonary Embolism Drug Revenue Share by Application (2023-2028)
Table 45. Pulmonary Embolism Drug Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Pulmonary Embolism Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Pulmonary Embolism Drug Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Pulmonary Embolism Drug Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Pulmonary Embolism Drug Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Pulmonary Embolism Drug Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Pulmonary Embolism Drug Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Pulmonary Embolism Drug Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Pulmonary Embolism Drug Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Pulmonary Embolism Drug Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Pulmonary Embolism Drug Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Pulmonary Embolism Drug Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Pulmonary Embolism Drug Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Pulmonary Embolism Drug Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Pulmonary Embolism Drug Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Pulmonary Embolism Drug Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Pulmonary Embolism Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Pulmonary Embolism Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Pulmonary Embolism Drug Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Pulmonary Embolism Drug Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Pulmonary Embolism Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Pulmonary Embolism Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Pulmonary Embolism Drug Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Pulmonary Embolism Drug Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Pulmonary Embolism Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Pulmonary Embolism Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Pulmonary Embolism Drug Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Pulmonary Embolism Drug Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Pulmonary Embolism Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Pulmonary Embolism Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Pulmonary Embolism Drug Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Pulmonary Embolism Drug Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Pulmonary Embolism Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Pulmonary Embolism Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Pulmonary Embolism Drug Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Pulmonary Embolism Drug Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Pulmonary Embolism Drug Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Pulmonary Embolism Drug Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Pulmonary Embolism Drug Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Pulmonary Embolism Drug Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Pulmonary Embolism Drug Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Pulmonary Embolism Drug Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Pulmonary Embolism Drug Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Pulmonary Embolism Drug Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Pulmonary Embolism Drug Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Pulmonary Embolism Drug Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Pulmonary Embolism Drug Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Pulmonary Embolism Drug Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Pulmonary Embolism Drug Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Pulmonary Embolism Drug Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Pulmonary Embolism Drug Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Pulmonary Embolism Drug Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Pulmonary Embolism Drug Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Pulmonary Embolism Drug Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Pulmonary Embolism Drug Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Pulmonary Embolism Drug Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Pulmonary Embolism Drug Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Pulmonary Embolism Drug Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Pulmonary Embolism Drug Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Pulmonary Embolism Drug Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Pulmonary Embolism Drug Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Pulmonary Embolism Drug Revenue by Country (2023-2028) & (US$ Million)
Table 107. Accu-Break Pharmaceuticals, Inc. Corporation Information
Table 108. Accu-Break Pharmaceuticals, Inc. Description and Major Businesses
Table 109. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Accu-Break Pharmaceuticals, Inc. Recent Developments
Table 112. Dong-A Socio Holdings Co. Ltd. Corporation Information
Table 113. Dong-A Socio Holdings Co. Ltd. Description and Major Businesses
Table 114. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Dong-A Socio Holdings Co. Ltd. Recent Developments
Table 117. F. Hoffmann-La Roche Ltd. Corporation Information
Table 118. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 119. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. F. Hoffmann-La Roche Ltd. Recent Developments
Table 122. Genentech, Inc. Corporation Information
Table 123. Genentech, Inc. Description and Major Businesses
Table 124. Genentech, Inc. Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Genentech, Inc. Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Genentech, Inc. Recent Developments
Table 127. Verseon Corp Corporation Information
Table 128. Verseon Corp Description and Major Businesses
Table 129. Verseon Corp Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Verseon Corp Pulmonary Embolism Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Verseon Corp Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Pulmonary Embolism Drug Distributors List
Table 135. Pulmonary Embolism Drug Customers List
Table 136. Pulmonary Embolism Drug Market Trends
Table 137. Pulmonary Embolism Drug Market Drivers
Table 138. Pulmonary Embolism Drug Market Challenges
Table 139. Pulmonary Embolism Drug Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Embolism Drug Product Picture
Figure 3. Global Pulmonary Embolism Drug Market Share by Type in 2021 & 2028
Figure 3. DS-9231 Product Picture
Figure 4. DS-1040 Product Picture
Figure 5. TRX-1 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pulmonary Embolism Drug Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Pulmonary Embolism Drug Report Years Considered
Figure 12. Global Pulmonary Embolism Drug Sales 2017-2028 (K Pcs)
Figure 13. Global Pulmonary Embolism Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Pulmonary Embolism Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Pulmonary Embolism Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Pulmonary Embolism Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Pulmonary Embolism Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Pulmonary Embolism Drug Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America Pulmonary Embolism Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Pulmonary Embolism Drug Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe Pulmonary Embolism Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Pulmonary Embolism Drug Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific Pulmonary Embolism Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Pulmonary Embolism Drug Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America Pulmonary Embolism Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Pulmonary Embolism Drug Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa Pulmonary Embolism Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Pulmonary Embolism Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Pulmonary Embolism Drug in the World: Market Share by Pulmonary Embolism Drug Revenue in 2021
Figure 30. Global Pulmonary Embolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Pulmonary Embolism Drug Sales Share by Country (2017-2028)
Figure 40. North America Pulmonary Embolism Drug Revenue Share by Country (2017-2028)
Figure 41. U.S. Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Pulmonary Embolism Drug Sales Share by Country (2017-2028)
Figure 48. Europe Pulmonary Embolism Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Pulmonary Embolism Drug Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Pulmonary Embolism Drug Revenue Share by Region (2017-2028)
Figure 60. China Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 63. India Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
Figure 71. Latin America Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
Figure 73. Latin America Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Pulmonary Embolism Drug Sales Share by Country (2017-2028)
Figure 75. Latin America Pulmonary Embolism Drug Revenue Share by Country (2017-2028)
Figure 76. Mexico Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Pulmonary Embolism Drug Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Pulmonary Embolism Drug Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Pulmonary Embolism Drug Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Pulmonary Embolism Drug Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Pulmonary Embolism Drug Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Pulmonary Embolism Drug Revenue Share by Country (2017-2028)
Figure 85. Turkey Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Pulmonary Embolism Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Pulmonary Embolism Drug Value Chain
Figure 89. Pulmonary Embolism Drug Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
